Evidence map›Paper›PMID 41639296›Full record

ArticleScientific reports2026

Selective Lis1 inactivation disrupts migration and positioning of cortical somatostatin interneurons.

A Pombero, R García-López, E Geijo-Barrientos, S Martínez

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

A Pombero *Instituto de Neurociencias, UMH-CSIC, Campus de San Juan, E- 03550- Alicante, Alicante, E-03550, Spain.
R García-López *Instituto de Neurociencias, UMH-CSIC, Campus de San Juan, E- 03550- Alicante, Alicante, E-03550, Spain.
E Geijo-BarrientosInstituto de Neurociencias, UMH-CSIC, Campus de San Juan, E- 03550- Alicante, Alicante, E-03550, Spain.
S MartínezInstituto de Neurociencias, UMH-CSIC, Campus de San Juan, E- 03550- Alicante, Alicante, E-03550, Spain. smartinez@umh.es.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

One subtype of interneurons, classified by their neurochemical properties, are somatostatin-positive (SST+) interneurons, which express somatostatin along with GABA and form synapses with both pyramidal neurons and other interneurons. SST+ interneurons originate in the medial ganglionic eminence and migrate tangentially to the cortex, making them potentially vulnerable to gene mutations linked to neuronal migration disorders. The Lis1 gene (Pafah1b1) regulates dynein-mediated motility, mitosis, and microtubule organization. Mutations in Lis1 are associated with lissencephaly and cortical disorganization. To investigate its role, we developed a mouse model with Lis1 deletion specifically in SST+ interneurons. We studied the anatomical and developmental effects of this deletion, focusing on tangential migration during embryonic and early postnatal stages. We analyzed SST+ interneuron numbers in the cingulate cortex (anterior and retrosplenial regions) of young mutant mice (P30). Our findings show a reduction in SST+ interneurons in mutants compared to controls, indicating impaired migration and/or maturation. Further research is needed to uncover the mechanisms behind this reduction and to determine its functional implications.

Indexed as

1-Alkyl-2-acetylglycerophosphocholine EsteraseCell MovementCerebral CortexInterneuronsMicrotubule-Associated ProteinsSomatostatinAnimalsMice1-Alkyl-2-acetylglycerophosphocholine EsteraseMicrotubule-Associated ProteinsPafah1b1 protein, mouseSomatostatinCingulate cortexLis1Somatostatin

Identifiers

PMID41639296
PMCPMC12923782

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.